A neutrophilic InflaMMation derIved marker as a predictor of iNfEctioN and exacerbaTion (IMMINENT)

Read full text Summarise with VIRAT
Authors: Bronagh Murray
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Individuals with cystic fibrosis (CF) experience chronic lung inflammation. This is due, in part, to abnormally high levels of neutrophils present in their lungs, releasing neutrophil elastase (NE), which damages lung tissue. Higher levels of NE in CF patients is associated with exacerbation, increased disease severity and increased likelihood of developing bronchiectasis. Excess levels of NE in the lung results in the cleavage of proteases. These cleaved protease fragments may be used as markers of NE activity in the airways and may act as biomarkers for inflammation, infection and/or bronchiectasis in CF. Using Randox biochip technology, we will utilise the antibodies against these cleaved protease fragments as part of a near-patient immunodiagnostic test. Sputum and BAL samples from patients with CF, will be tested on these biochips and correlated to clinical parameters including microbiological and inflammatory data. Thesis is embargoed until 31 December 2027.

Fields of Study & Subjects

Cystic Fibrosis Research Advances Inflammation biomarkers and pathways Chronic Obstructive Pulmonary Disease (COPD) Research

Publication details

Journal / source
Research Portal (Queen's University Belfast)
Publication date
1 October 2026
Language
EN
Document type
Thesis